V
Vaxcyte, Inc. (PCVX)
NMS – Real vaqt narxi. Valyuta: USD
56.52
+2.84 (5.29%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
56.00
-0.52 (-0.92%)
Bozordan keyin: Jun 26, 2026, 5:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
56.52
+2.84 (5.29%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
56.00
-0.52 (-0.92%)
Bozordan keyin: Jun 26, 2026, 5:00 PM EDT
| Tarkibi | |
|---|---|
| 0.53% | Insayderlar egalik qilgan aksiyalar ulushi |
| 114.61% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 115.22% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 457 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Janus Henderson Group PLC | 16.58M | 2026-03-31 | 11.48% | $852.66M |
| FMR, LLC | 16.49M | 2026-03-31 | 11.42% | $848.39M |
| T. Rowe Price Investment Management, Inc. | 12.13M | 2026-03-31 | 8.40% | $623.76M |
| RA Capital Management, L.P. | 11.47M | 2026-03-31 | 7.95% | $590.25M |
| Blackrock Inc. | 10.97M | 2026-03-31 | 7.60% | $564.39M |
| Vanguard Portfolio Management LLC | 6.28M | 2026-03-31 | 4.35% | $323.02M |
| Vanguard Capital Management LLC | 6.27M | 2026-03-31 | 4.34% | $322.36M |
| Wellington Management Group, LLP | 5.61M | 2026-03-31 | 3.89% | $288.81M |
| Paradigm Biocapital Advisors LP | 4.79M | 2026-03-31 | 3.32% | $246.55M |
| State Street Corporation | 4.44M | 2026-03-31 | 3.08% | $228.42M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.59M | 2026-03-31 | 3.18% | $235.90M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.32M | 2026-03-31 | 2.30% | $170.70M |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.28M | 2026-01-31 | 2.27% | $168.89M |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 2.94M | 2026-04-30 | 2.03% | $151.03M |
| iShares Trust-iShares Russell 2000 ETF | 2.92M | 2026-04-30 | 2.02% | $150.26M |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 2.78M | 2026-02-28 | 1.93% | $155.36M |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.54M | 2026-03-31 | 1.76% | $130.65M |
| JANUS INVESTMENT FUND-Janus Henderson Forty Fund | 2.50M | 2026-05-31 | 1.73% | $128.63M |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 2.27M | 2026-05-31 | 1.57% | $116.76M |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 1.92M | 2025-12-31 | 1.33% | $98.52M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.86M | 2026-03-31 | 1.29% | $95.61M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.65M | 2026-04-30 | 1.14% | $84.69M |
| Fidelity Advisor Series I-Fidelity Advisor Growth Opportunities Fund | 1.48M | 2026-02-28 | 1.03% | $84.60M |